2011
DOI: 10.1016/j.urology.2010.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Pyridoxine and Dietary Counseling for the Management of Idiopathic Hyperoxaluria in Stone-forming Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 47 publications
(24 citation statements)
references
References 28 publications
2
21
1
Order By: Relevance
“…B6-deficient rats, 34 and pyridoxine is known to be an effective first-line therapy to decrease hyperoxaluria in patients who develop stones. 16 Ascorbic acid, as well as other radical scavengers, and the antioxidant enzymes decreased in urolithic condition, suggestive of the active involvement of free radical-mediated lipid peroxidation-induced membrane damage in kidney. 35 Vit.…”
Section: Discussionmentioning
confidence: 94%
“…B6-deficient rats, 34 and pyridoxine is known to be an effective first-line therapy to decrease hyperoxaluria in patients who develop stones. 16 Ascorbic acid, as well as other radical scavengers, and the antioxidant enzymes decreased in urolithic condition, suggestive of the active involvement of free radical-mediated lipid peroxidation-induced membrane damage in kidney. 35 Vit.…”
Section: Discussionmentioning
confidence: 94%
“…Large cohort studies have shown an inverse association between pyridoxine intake and the risk of stone formation, 19 and a retrospective study suggested that pyridoxine, combined with dietary modification, can reduce urinary oxalate in hyperoxaluric stone formers. 62 Citrate Urinary citrate inhibits calcium stone formation by complexing with urinary calcium and lowering ionized calcium and by inhibiting calcium oxalate and calcium phosphate crystal growth and aggregation. 63 Renal citrate excretion is modulated primarily by the systemic acid-base balance; acidosis decreases and alkalosis increases renal tubular production and excretion of citrate.…”
Section: Sodiummentioning
confidence: 99%
“…However, it has only been demonstrated to be beneficial in certain patients with type 1 primary hyperoxaluria [33]. Its utilization in patients with idiopathic hyperoxaluria has not been substantiated with well-designed studies [34]. In theory, it could benefit such patients as it may promote the activity of alanine glyoxylate aminotransferase, which diverts glyoxylate away from oxalate synthesis or potentially stimulates other aminotransferases.…”
Section: Other Strategies To Lower Urinary Oxalate Excretionmentioning
confidence: 99%